Evidence suggests that an antibiotic derived from the Streptomyces bacterium may help in the fight against the rare cancer Malignant Mesothelioma/Asbestos Cancer.

A newly-published research study gave us another hope for Mesothelioma, that rare disease.
In the past few years we’ve heard about Treating Mesothelioma with immunotherapy, Graphene, beside the Traditional treatments—chemotherapy, surgery, and/or radiation.
Scientists from several Korean institutions suggest that Manumycin A triggers apoptosis, or natural cell death, in malignant mesothelioma cells. This antibiotic is a natural product derived from Streptomyces bacteria. It is known to have anticancer properties, which may offer a new way to treat the disease. Surviving Mesothelioma has just posted an article on the new Korean study. To read more about Manumycin A and its effects on mesothelioma cells, see Antibiotic May Help Fight Mesothelioma, now available on the Surviving Mesothelioma website.

Mesothelioma and Antibiotic;

Malignant mesothelioma is one of the rarest cancer and one of the deadliest types because it is highly resistant to standard cancer treatments. The cause of malignant mesothelioma is known to be by inhalant asbestos fibers for a long period of time. These tiny inhalant fibers are ppt. in the mesothelium membrane lining many organs. Symptoms are not diagnosed except after a long latent period of the disease which made it difficult to be treated. Treating Mesothelioma with an Antibiotic that has anticancer effects if comes to true; it will be a good hope for those critical cases.
Treating Mesothelioma with an Antibiotic have been rounded for such time but “This is the first study on the potential of Manumycin A in mesothelioma treatment, but it is not the first study on its anticancer properties,” says Alex Strauss, Managing Editor of Surviving Mesothelioma.
An antibiotic known to have anticancer properties such as Manumycin A, may be a new and better way to treat mesothelioma victims around the world.
Thus, the aim of the present study was to use the cancer preventive and chemotherapeutic effects of Manumycin A on malignant pleural mesothelioma (MPM) as it inhibits the cancers cell viability and leading to cell death pathway.
It was found that the higher the concentration of Manumycin A used, the greater the response of the mesothelioma tumor cells…this demonstrated result was in an article appeared in a recent issue of Oncology Reports. For more scientific details see; www.spandidos-publications.com.

Treating Mesothelioma with an Antibiotic;

Manumycin A is a natural product made from a bacterium called Streptomyces parvulus and has been reported to have anti-carcinogenic and anti-biotic properties. Streptomyces produce over two-thirds of the clinically useful antibiotics of natural origin. The studies demonstrated that Manu A exerted anticancer effects that lead to cell death pathway.
Source: survivingmesothelioma, spandidos-publications